{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:09:00Z","timestamp":1762250940478,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:00:00Z","timestamp":1745712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","award":["242300421282","242300421411"],"award-info":[{"award-number":["242300421282","242300421411"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.imlet.2025.107027","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T12:56:05Z","timestamp":1745412965000},"page":"107027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification of S100A9 as a target for diagnosis and treatment of Crohn\u2019s Disease after Vedolizumab treatment failure"],"prefix":"10.1016","volume":"275","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8583-4528","authenticated-orcid":false,"given":"Yanru","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruixian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijia","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junzhi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimeng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinji","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiankun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baisui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.imlet.2025.107027_bib0001","doi-asserted-by":"crossref","first-page":"113","DOI":"10.25122\/jml-2018-0075","article-title":"A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease","volume":"12","author":"Seyedian","year":"2019","journal-title":"J. Med. Life"},{"key":"10.1016\/j.imlet.2025.107027_bib0002","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.2147\/JIR.S422881","article-title":"Identification of targets for subsequent treatment of Crohn's Disease patients after failure of anti-TNF therapy","volume":"16","author":"Yao","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.imlet.2025.107027_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7247238","article-title":"A comprehensive review and update on the pathogenesis of inflammatory bowel disease","volume":"2019","author":"Guan","year":"2019","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.imlet.2025.107027_bib0004","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41572-020-0193-x","article-title":"Author correction: crohn's disease","volume":"6","author":"Roda","year":"2020","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"2","key":"10.1016\/j.imlet.2025.107027_bib0005","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/ibd\/izy235","article-title":"Increased burden of psychiatric disorders in inflammatory bowel disease","volume":"25","author":"Bernstein","year":"2019","journal-title":"Inflamm. Bowel. Dis."},{"issue":"7","key":"10.1016\/j.imlet.2025.107027_bib0006","article-title":"Vedolizumab for induction and maintenance of remission in Crohn's disease","volume":"7","author":"Hui","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.imlet.2025.107027_bib0007","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/ecco-jcc\/jjx143","article-title":"Vedolizumab in IBD-lessons from real-world experience; A systematic review and pooled analysis","volume":"12","author":"Engel","year":"2018","journal-title":"J. Crohns. Colitis."},{"issue":"5","key":"10.1016\/j.imlet.2025.107027_bib0008","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/ibd\/izad138","article-title":"Real-world effectiveness of Vedolizumab vs Anti-TNF in biologic-naive Crohn's Disease patients: a 2-year propensity-score-adjusted analysis from the VEDOIBD-Study","volume":"30","author":"Bokemeyer","year":"2024","journal-title":"Inflamm. Bowel. Dis."},{"issue":"5","key":"10.1016\/j.imlet.2025.107027_bib0009","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/apt.16723","article-title":"Trends in the use of biologicals and their treatment outcomes among patients with inflammatory bowel diseases - a Danish nationwide cohort study","volume":"55","author":"Zhao","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.imlet.2025.107027_bib0010","doi-asserted-by":"crossref","DOI":"10.1177\/17562848231159452","article-title":"Is there an optimal sequence of biologic therapies for inflammatory bowel disease?","volume":"16","author":"Bressler","year":"2023","journal-title":"Ther. Adv Gastroenterol."},{"key":"10.1016\/j.imlet.2025.107027_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2024.106681","article-title":"Whole-transcriptome sequencing of phagocytes reveals a ceRNA network contributing to natural resistance to tuberculosis infection","volume":"192","author":"Ran","year":"2024","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.imlet.2025.107027_bib0012","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12891-024-07396-z","article-title":"Identification and bioinformatics analysis of lncRNAs in serum of patients with ankylosing spondylitis","volume":"25","author":"Kou","year":"2024","journal-title":"BMC. Musculoskelet. Disord."},{"issue":"3","key":"10.1016\/j.imlet.2025.107027_bib0013","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.compbiolchem.2011.04.002","article-title":"A local average connectivity-based method for identifying essential proteins from the network level","volume":"35","author":"Li","year":"2011","journal-title":"Comput. Biol. Chem."},{"issue":"2","key":"10.1016\/j.imlet.2025.107027_bib0014","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.immuni.2023.01.002","article-title":"The landscape of immune dysregulation in Crohn's disease revealed through single-cell transcriptomic profiling in the ileum and colon","volume":"56","author":"Kong","year":"2023","journal-title":"Immunity."},{"issue":"6","key":"10.1016\/j.imlet.2025.107027_bib0015","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/nar\/gkp1137","article-title":"The Sanger FASTQ file format for sequences with quality scores, and the Solexa\/Illumina FASTQ variants","volume":"38","author":"Cock","year":"2010","journal-title":"Nucleic. Acids. Res."},{"issue":"4","key":"10.1016\/j.imlet.2025.107027_bib0016","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"issue":"W1","key":"10.1016\/j.imlet.2025.107027_bib0017","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic. Acids. Res."},{"issue":"1","key":"10.1016\/j.imlet.2025.107027_bib0018","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.imlet.2025.107027_bib0019","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15338-9","article-title":"Honghua extract mediated potent inhibition of COVID-19 host cell pathways","volume":"12","author":"Madikyzy","year":"2022","journal-title":"Sci. Rep."},{"issue":"Database issue","key":"10.1016\/j.imlet.2025.107027_bib0020","article-title":"KEGG for linking genomes to life and the environment","volume":"36","author":"Kanehisa","year":"2008","journal-title":"Nucleic. Acids. Res."},{"issue":"D1","key":"10.1016\/j.imlet.2025.107027_bib0021","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic. Acids. Res."},{"issue":"3","key":"10.1016\/j.imlet.2025.107027_bib0022","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ncrna.2024.02.004","article-title":"Noncoding RNA-associated competing endogenous RNA networks in trastuzumab-induced cardiotoxicity","volume":"9","author":"Xie","year":"2024","journal-title":"Noncoding. RNa Res."},{"issue":"Suppl 4","key":"10.1016\/j.imlet.2025.107027_bib0023","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8 Suppl 4","author":"Chin","year":"2014","journal-title":"BMC. Syst. Biol."},{"issue":"11","key":"10.1016\/j.imlet.2025.107027_bib0024","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.imlet.2025.107027_bib0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2105-4-2","article-title":"An automated method for finding molecular complexes in large protein interaction networks","volume":"4","author":"Bader","year":"2003","journal-title":"BMC Bioinform."},{"issue":"1","key":"10.1016\/j.imlet.2025.107027_bib0026","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1038\/s41467-019-13475-w","article-title":"A truncating mutation in the autophagy gene UVRAG drives inflammation and tumorigenesis in mice","volume":"10","author":"Quach","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imlet.2025.107027_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102707","article-title":"The deubiquitinase USP11 ameliorates intervertebral disc degeneration by regulating oxidative stress-induced ferroptosis via deubiquitinating and stabilizing Sirt3","volume":"62","author":"Zhu","year":"2023","journal-title":"Redox. Biol."},{"key":"10.1016\/j.imlet.2025.107027_bib0028","article-title":"Dehydrocostus lactone suppresses dextran sulfate sodium-induced colitis by targeting the IKKalpha\/beta-NF-kappaB and Keap1-Nrf2 signalling pathways","volume":"13","author":"Yuan","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.imlet.2025.107027_bib0029","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.cell.2020.04.055","article-title":"Single-cell mapping of Human brain cancer reveals tumor-specific instruction of tissue-invading leukocytes","volume":"181","author":"Friebel","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.imlet.2025.107027_bib0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/j.gastro.2016.10.020","article-title":"Understanding and preventing the global increase of inflammatory bowel disease","volume":"152","author":"Kaplan","year":"2017","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.imlet.2025.107027_bib0031","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1007\/s10620-021-07205-w","article-title":"What's new in the postoperative management of Crohn's Disease?","volume":"67","author":"Dasharathy","year":"2022","journal-title":"Dig. Dis. Sci."},{"issue":"4","key":"10.1016\/j.imlet.2025.107027_bib0032","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22220","article-title":"Vedolizumab in the treatment of Crohn's disease: a promising therapeutic approach","volume":"85","author":"Zargar","year":"2024","journal-title":"Drug Dev. Res."},{"issue":"3","key":"10.1016\/j.imlet.2025.107027_bib0033","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/apt.14167","article-title":"One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study","volume":"46","author":"Amiot","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.imlet.2025.107027_bib0034","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/apt.15294","article-title":"Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study","volume":"50","author":"Amiot","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.imlet.2025.107027_bib0035","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/ajg.2016.342","article-title":"Serum Calprotectin: a novel diagnostic and prognostic marker in inflammatory bowel diseases","volume":"111","author":"Kalla","year":"2016","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107027_bib0036","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cellimm.2013.04.004","article-title":"Serum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitis","volume":"282","author":"Cury","year":"2013","journal-title":"Cell Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2025.107027_bib0037","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ajg.2019.07.002","article-title":"The value of mRNA expression of S100A8 and S100A9 as blood-based biomarkers of inflammatory bowel disease","volume":"20","author":"Azramezani Kopi","year":"2019","journal-title":"Arab. J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.imlet.2025.107027_bib0038","first-page":"599","article-title":"Analysis on clinical features of patients with ulcerative colitis associated colorectal cancer]","volume":"100","author":"Zhang","year":"2020","journal-title":"Zhonghua Yi Xue Za Zhi."},{"key":"10.1016\/j.imlet.2025.107027_bib0039","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3389\/fimmu.2017.01774","article-title":"Suppression colitis and colitis-associated colon cancer by anti-S100a9 antibody in mice","volume":"8","author":"Zhang","year":"2017","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.imlet.2025.107027_bib0040","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1136\/annrheumdis-2014-206517","article-title":"Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis","volume":"74","author":"Schelbergen","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2025.107027_bib0041","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/978-1-0716-1382-5_26","article-title":"Mouse models of intestinal fibrosis","volume":"2299","author":"Li","year":"2021","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.imlet.2025.107027_bib0042","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41575-023-00871-3","article-title":"Neutrophils: from IBD to the gut microbiota","volume":"21","author":"Danne","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107027_bib0043","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.1968257","article-title":"Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease","volume":"13","author":"Li","year":"2021","journal-title":"Gut. Microbes."},{"issue":"14","key":"10.1016\/j.imlet.2025.107027_bib0044","first-page":"1647","article-title":"Inflammatory bowel disease group, C.S.o.G.C.M.A. and C. Inflammatory bowel disease quality control center of, 2023 Chinese national clinical practice guideline on diagnosis and management of Crohn's disease","volume":"137","year":"2024","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"1","key":"10.1016\/j.imlet.2025.107027_bib0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S2468-1253(19)30186-4","article-title":"De-escalation of immunomodulator and biological therapy in inflammatory bowel disease","volume":"5","author":"Chapman","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.imlet.2025.107027_bib0046","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1053\/j.gastro.2019.08.043","article-title":"Efficacy and safety of Mirikizumab in a randomized phase 2 study of patients with ulcerative colitis","volume":"158","author":"Sandborn","year":"2020","journal-title":"Gastroenterology"},{"issue":"10080","key":"10.1016\/j.imlet.2025.107027_bib0047","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0140-6736(17)30570-6","article-title":"Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study","volume":"389","author":"Feagan","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.imlet.2025.107027_bib0048","first-page":"77","article-title":"Efficacy and safety of MEDI2070, an antibody against interleukin 23","volume":"153","author":"Sands","year":"2017","journal-title":"Patients Moder. Sev. Crohn's Dis."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825000604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825000604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:04:41Z","timestamp":1762250681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247825000604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":48,"alternative-id":["S0165247825000604"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107027","relation":{},"ISSN":["0165-2478"],"issn-type":[{"type":"print","value":"0165-2478"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of S100A9 as a target for diagnosis and treatment of Crohn\u2019s Disease after Vedolizumab treatment failure","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}],"article-number":"107027"}}